We are pleased to announce that our CEO, Jan Hendriks, will be representing our company at the highly anticipated BIO CEO & Investor Conference in New York City on February 27-28!

We are thrilled to announce our active participation in the upcoming 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) Tech Fair, scheduled to take place in Florence from 6th to 9th March 2024.

Jan Hendriks, CEO of Biotts, will be at JPM Week 2024, and he’s eager to connect with investors interested in our revolutionary, patented transdermal drug delivery technology. Don’t miss the chance to explore partnership opportunities and discuss the future of drug delivery!

We are pleased to share the news of our strategic collaboration with BIOTON S.A. Together, we embark on a groundbreaking proof-of-concept project aimed at transdermal insulin delivery – a pioneering initiative set to make history.

Bio Europe 2023 in Munich was a huge success for Biotts.

Join us at BioEurope 2023 in Munich!
We’re thrilled to extend a warm invitation to you for our exclusive presentation on November 6th at 3:30 pm.